Literature DB >> 9440661

Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study.

G Howard1, L E Wagenknecht, G L Burke, A Diez-Roux, G W Evans, P McGovern, F J Nieto, G S Tell.   

Abstract

CONTEXT: Cigarette smoking is a powerful risk factor for incident heart disease and stroke, but the relationship of active and passive smoking with the progression of atherosclerosis has not been described.
OBJECTIVE: To examine the impact of active smoking and exposure to environmental tobacco smoke (ETS) on the progression of atherosclerosis.
DESIGN: A longitudinal assessment of the relationship between smoking exposure evaluated at the initial visit and the 3-year change in atherosclerosis.
SETTING: A population-based cohort of middle-aged adults from 4 communities in the United States. PARTICIPANTS: A total of 10914 participants from the Atherosclerosis Risk in Communities (ARIC) study enrolled between 1987 and 1989. MAIN OUTCOME MEASURE: Change in atherosclerosis from baseline to the 3-year follow-up as indexed by intimal-medial thickness of the carotid artery assessed by ultrasound and adjusted for demographic characteristics, cardiovascular risk factors, and lifestyle variables.
RESULTS: Exposure to cigarette smoke was associated with progression of atherosclerosis. Relative to never smokers and after adjustment for demographic characteristics, cardiovascular risk factors, and lifestyle variables, current cigarette smoking was associated with a 50% increase in the progression of atherosclerosis (mean progression rate over 3 years, 43.0 microm for current and 28.7 microm for never smokers, regardless of ETS exposure), and past smoking was associated with a 25% increase (mean progression rate over 3 years, 35.8 microm for past smokers and 28.7 microm for never smokers). Relative to those not exposed to ETS, exposure to ETS was associated with a 20% increase (35.2 microm for those exposed to ETS vs 29.3 microm for those not exposed). The impact of smoking on atherosclerosis progression was greater for subjects with diabetes and hypertension. Although more pack-years of exposure was independently associated with faster progression (P<.001), after controlling for the number of pack-years, the progression rates of current and past smokers did not differ (P=.11).
CONCLUSIONS: Both active smoking and ETS exposure are associated with the progression of an index of atherosclerosis. Smoking is of particular concern for patients with diabetes and hypertension. The fact that pack-years of smoking but not current vs past smoking was associated with progression of atherosclerosis suggests that some adverse effects of smoking may be cumulative and irreversible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9440661     DOI: 10.1001/jama.279.2.119

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  167 in total

1.  Environmental tobacco smoke and periodontal disease in the United States.

Authors:  S J Arbes; H Agústsdóttir; G D Slade
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

2.  How many deaths are caused by second hand cigarette smoke?

Authors:  A Woodward; M Laugesen
Journal:  Tob Control       Date:  2001-12       Impact factor: 7.552

3.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

4.  Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.

Authors:  Li-Shiun Chen; Timothy B Baker; Megan E Piper; Naomi Breslau; Dale S Cannon; Kimberly F Doheny; Stephanie M Gogarten; Eric O Johnson; Nancy L Saccone; Jen C Wang; Robert B Weiss; Alison M Goate; Laura Jean Bierut
Journal:  Am J Psychiatry       Date:  2012-07       Impact factor: 18.112

5.  Secondhand smoke exposure is associated with increased carotid artery intima-media thickness: the Bogalusa Heart Study.

Authors:  Wei Chen; Miaoying Yun; Camilo Fernandez; Shengxu Li; Dianjianyi Sun; Chin-Chih Lai; Yingxiao Hua; Fu Wang; Tao Zhang; Sathanur R Srinivasan; Carolyn C Johnson; Gerald S Berenson
Journal:  Atherosclerosis       Date:  2015-04-07       Impact factor: 5.162

6.  Early trauma and inflammation: role of familial factors in a study of twins.

Authors:  Cherie Rooks; Emir Veledar; Jack Goldberg; J Douglas Bremner; Viola Vaccarino
Journal:  Psychosom Med       Date:  2012-01-27       Impact factor: 4.312

7.  Preoperative cigarette smoking and short-term morbidity and mortality after cardiac surgery: a meta-analysis.

Authors:  Nicholas Gregory Ross Bayfield; Adrian Pannekoek; David Hao Tian
Journal:  Heart Asia       Date:  2018-10-24

8.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

9.  Long-Term Consequences of Early Trauma on Coronary Heart Disease: Role of Familial Factors.

Authors:  Cherie Rooks; Emir Veledar; Jack Goldberg; John Votaw; Amit Shah; J Douglas Bremner; Viola Vaccarino
Journal:  J Trauma Stress       Date:  2015-09-21

10.  Role of endoplasmic reticulum stress in acrolein-induced endothelial activation.

Authors:  Petra Haberzettl; Elena Vladykovskaya; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.